InMed Pharmaceuticals Inc. (INM): Price and Financial Metrics

InMed Pharmaceuticals Inc. (INM): $0.23

0.02 (-7.78%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

F

Add INM to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#328 of 388

in industry

INM Price/Volume Stats

Current price $0.23 52-week high $0.78
Prev. close $0.25 52-week low $0.12
Day low $0.23 Volume 823,806
Day high $0.26 Avg. volume 2,439,094
50-day MA $0.25 Dividend yield N/A
200-day MA $0.29 Market Cap 3.10M

INM Stock Price Chart Interactive Chart >


InMed Pharmaceuticals Inc. (INM) Company Bio


InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.


INM Latest News Stream


Event/Time News Detail
Loading, please wait...

INM Latest Social Stream


Loading social stream, please wait...

View Full INM Social Stream

INM Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!